New genotyping research from the Center for Addiction and Mental Health found that the enzyme known to metabolize both the smoking cessation drug bupropion and nicotine is highly genetically variable in all ethnicities and influences smoking cessation. This finding is a step toward being able to tailor smoking cessation treatment to individuals based on their unique genetic make-up.
Quitting Smoking: Genetic Research Shows Promise For Personalized Treatment
- ScienceDaily
- 18. 9 2007 (17:00)